392 related articles for article (PubMed ID: 24161322)
1. Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).
Mentz RJ; Broderick S; Shaw LK; Fiuzat M; O'Connor CM
J Am Coll Cardiol; 2014 Jan; 63(3):251-8. PubMed ID: 24161322
[TBL] [Abstract][Full Text] [Related]
2. Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events.
Mentz RJ; Broderick S; Shaw LK; Chiswell K; Fiuzat M; O'Connor CM
Eur J Heart Fail; 2014 Aug; 16(8):854-60. PubMed ID: 24975128
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease).
Mentz RJ; Fiuzat M; Shaw LK; Phillips HR; Borges-Neto S; Felker GM; O'Connor CM
Am J Cardiol; 2012 May; 109(9):1272-7. PubMed ID: 22325975
[TBL] [Abstract][Full Text] [Related]
4. Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center.
Grubb AF; Pumill CA; Greene SJ; Wu A; Chiswell K; Mentz RJ
Am Heart J; 2020 Dec; 230():25-34. PubMed ID: 32980363
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease).
Banks A; Broderick S; Chiswell K; Shaw L; Devore A; Fiuzat M; O'Connor C; Felker GM; Velazquez E; Mentz R
Am J Cardiol; 2017 Jun; 119(11):1703-1709. PubMed ID: 28395884
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials.
Cunningham JW; Vaduganathan M; Claggett BL; John JE; Desai AS; Lewis EF; Zile MR; Carson P; Jhund PS; Kober L; Pitt B; Shah SJ; Swedberg K; Anand IS; Yusuf S; McMurray JJV; Pfeffer MA; Solomon SD
JACC Heart Fail; 2020 Aug; 8(8):618-626. PubMed ID: 32387067
[TBL] [Abstract][Full Text] [Related]
7. Implications of coronary artery disease in heart failure with preserved ejection fraction.
Hwang SJ; Melenovsky V; Borlaug BA
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
[TBL] [Abstract][Full Text] [Related]
10. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Badar AA; Perez-Moreno AC; Jhund PS; Wong CM; Hawkins NM; Cleland JG; van Veldhuisen DJ; Wikstrand J; Kjekshus J; Wedel H; Watkins S; Gardner RS; Petrie MC; McMurray JJ
Eur Heart J; 2014 Dec; 35(48):3426-33. PubMed ID: 25265976
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme.
Badar AA; Perez-Moreno AC; Hawkins NM; Brunton AP; Jhund PS; Wong CM; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Gardner RS; Petrie MC; McMurray JJ
Eur J Heart Fail; 2015 Feb; 17(2):196-204. PubMed ID: 25678097
[TBL] [Abstract][Full Text] [Related]
12. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.
Mentz RJ; Allen BD; Kwasny MJ; Konstam MA; Udelson JE; Ambrosy AP; Fought AJ; Vaduganathan M; O'Connor CM; Zannad F; Maggioni AP; Swedberg K; Bonow RO; Gheorghiade M
Eur J Heart Fail; 2013 Jan; 15(1):61-8. PubMed ID: 22968743
[TBL] [Abstract][Full Text] [Related]
13. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
[TBL] [Abstract][Full Text] [Related]
14. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
15. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
[TBL] [Abstract][Full Text] [Related]
16. Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study).
Beatty AL; Spertus JA; Whooley MA
Am J Cardiol; 2014 Oct; 114(7):997-1002. PubMed ID: 25110069
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of coronary CT angiography in heart failure patients with preserved ejection fraction.
Yu MM; Zuo WX; Zhao X; Tang XL; Chen YY; Dong LL; Shu XH; Jin H; Zeng MS
Eur Radiol; 2023 May; 33(5):3052-3063. PubMed ID: 36629927
[TBL] [Abstract][Full Text] [Related]
19. H2FPEF Score as a Prognostic Value in HFpEF Patients.
Sueta D; Yamamoto E; Nishihara T; Tokitsu T; Fujisue K; Oike F; Takae M; Usuku H; Takashio S; Arima Y; Suzuki S; Nakamura T; Ito M; Kanazawa H; Sakamoto K; Kaikita K; Tsujita K
Am J Hypertens; 2019 Oct; 32(11):1082-1090. PubMed ID: 31271191
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
